Injection of Vasopressin drug during laparoscopic cystectomy helps in preserving ovarain reserve

Not Applicable

• Conditions: Health Condition 1: D279- Benign neoplasm of unspecified ovary

• Registration Number: CTRI/2021/07/035186
• Lead Sponsor: JIPMER

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

Women undergoing laparoscopic ovarian cystectomy for benign ovarian cysts.

1.Age 18-40 years

2.Presence of unilateral benign ovarian cyst

3.Size of the cyst between 6-15 cm

Exclusion Criteria

1.Pregnancy

2.Active pelvic inflammatory disease (based on clinical criteria)

3.Suspected or proven genital or extra genital malignan-cy

4.Polycystic ovarian syndrome according to Rotterdam criteria

Inclusion criteria: Women undergoing laparoscopic ovarian cystectomy for benign ovarian cysts.

1.Age 18-40 years

2.Presence of unilateral benign ovarian cyst

3.Size of the cyst between 6-15 cm

1.Pregnancy

2.Active pelvic inflammatory disease (based on clinical criteria)

3.Suspected or proven genital or extra genital malignancy

4.Polycystic ovarian syndrome according to Rotterdam criteria

5.Premature menopause (cessation of menstrual periods before 40years age)

6.History of previous adnexal surgery

7. Women with cardiopulmonary diseases, bleeding diathesis and renal disease.

Study & Design

• Study Type: Interventional
• Study Design: Not specified